Lasting Benefit Seen For Vagus Nerve Stimulation In Treatment Resistant Depression Mednews
Автор: RX Card Club
Загружено: 2026-01-22
Просмотров: 0
Описание: A study published in the International Journal of Neuropsychopharmacology found that among patients with treatment-resistant major depressive disorder (MDD), most of those who achieve benefit with 12 months of adjunctive vagus nerve stimulation (VNS) maintain that benefit at 18 and 24 months. The researchers found that benefit was maintained for most participants with substantial benefit (18- and 24-month median, 78.8 and 79.0 percent, respectively, across five measures) and for participants with at least meaningful benefit at 12 months (18- and 24-month median, 83.1 and 81.3 percent, respectively, across seven measures). Many participants who did not achieve meaningful benefit at 12 months achieved it at 18 and 24 months (median, 30.6 and 37.8 percent, respectively). Changes in psychotropic medications or interventional psychiatric modalities did not account for the strong maintenance of benefit. The study's lead author stated that these results are "highly atypical" as most studies of markedly treatment-resistant depression have very poor sustainability of benefit, certainly not at two years. | #VagusNerveStimulation #treatmentresistantdepression #lastingbenefit #MedNews #health #healthnews #medicine #medical #medicalnews #healthcare
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
